MTOR and neoplasm: We previously reported that orlistat exhibited anti-proliferative activity against EC cells in vitro by inducing cell cycle G1 arrest and cellular stress and inhibiting fatty acid metabolism and the mTOR pathway, indicating that orlistat deserves further anti-tumor studies in vivo for EC (17).